HUM delivers 10 g of Fibersol-2, matching the dose that raised postprandial GLP-1 by roughly 40% in trial conditions
Obesity is a chronic disease One of the greatest misconceptions surrounding obesity is that it is simply a matter of willpower
In analyses of people with pre-existing SUDs, GLP-1 receptor agonist use (versus SGLT-2 inhibitor use) was associated with a reduced risk of subsequent adverse clinical events, including SUD related emergency department visits, hospital admissions, and mortality, drug overdose, and suicidal ideation or attempt
Join the Amandean superhuman family today
You can address all of these with lifestyle changes to make sure youre resting, eating, and drinking enough
Cardiovascular-kidney-metabolic health: A presidential advisory from the American Heart Association